scispace - formally typeset
K

Keyla Lazardi

Researcher at Venezuelan Institute for Scientific Research

Publications -  7
Citations -  646

Keyla Lazardi is an academic researcher from Venezuelan Institute for Scientific Research. The author has contributed to research in topics: Chagas disease & Biological activity. The author has an hindex of 7, co-authored 7 publications receiving 632 citations.

Papers
More filters
Journal ArticleDOI

Cure of Short- and Long-Term Experimental Chagas' Disease Using D0870

TL;DR: D0870 was able to prevent death and induced parasitological cure in 70 to 90 percent of animals and may be useful in the treatment of human long-term Chagas' disease, a condition that is currently incurable.
Journal ArticleDOI

Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.

TL;DR: Results confirm the synergic action against the proliferative stages of T. cruzi both in vitro and in vivo and suggest that mevinolin combined with azoles, such as ketoconazole, can be used in the treatment of human Chagas' disease.
Journal ArticleDOI

Antiproliferative Effects of △24(25) Sterol Methyl Transferase Inhibitors on Trypanosoma (Schizotrypanum) cruzi: In vitro and in vivo Studies

TL;DR: Two sterol analogs previously reported as potent inhibitors of Δ24(25) sterol methyl transferase are studied for antiproliferative effects of yeasts and fungi on epim.
Journal ArticleDOI

Inhibition of phosphatidylcholine biosynthesis and cell proliferation in trypanosomacruzi by ajoene, an antiplatelet compound isolated from garlic

TL;DR: One important factor associated with the antiproliferative effects of ajoene against T. cruzi is its specific alteration of the phospholipid composition of these cells, particularly the mitochondrion and endoplasmatic reticulum.